Evidence map›Paper›PMID 41904260›Full record

ArticleScientific reports2026

Machine learning-predicted chromatin organization landscape across pediatric tumors.

Ketrin Gjoni, Shu Zhang, Rachel E Yan, Bo Zhang, Daniel Miller, Jeffrey P Greenfield, Adam Resnick, Nadia Dahmane, Katherine S Pollard

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Ketrin Gjoni *Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, 94158, USA.
Shu Zhang *Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, 94158, USA.
Rachel E YanDepartment of Neurological Surgery, Weill Cornell Medicine, New York, NY, 10065, USA.
Bo ZhangCenter for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Daniel MillerCenter for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Jeffrey P GreenfieldDepartment of Neurological Surgery, Weill Cornell Medicine, New York, NY, 10065, USA.
Adam ResnickCenter for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Nadia DahmaneDepartment of Neurological Surgery, Weill Cornell Medicine, New York, NY, 10065, USA.
Katherine S PollardGladstone Institute of Data Science and Biotechnology, San Francisco, CA, 94158, USA. katherine.pollard@gladstone.ucsf.edu.

Funding

NIH HHS R03-DE032505
6 · The paper itself

Abstract

Structural variants (SVs) are increasingly recognized as important contributors to oncogenesis through their effects on 3D genome folding. Recent advances in whole-genome sequencing have enabled large-scale profiling of SVs across diverse tumors, yet experimental characterization of their individual impact on genome folding remains infeasible. Here, we leveraged a convolutional neural network, Akita, to predict disruptions in genome folding caused by somatic SVs identified in 61 tumor types from the Children's Brain Tumor Network dataset. Our analysis reveals significant variability in SV-induced disruptions across tumor types, with the most disruptive SVs coming from lymphomas and sarcomas, metastatic tumors, and germline cell tumors. Dimensionality reduction of disruption scores identified five recurrently disrupted regions enriched for high-impact SVs across multiple tumors. Some of these regions are highly disrupted despite not being highly mutated, and harbor tumor-associated genes and transcriptional regulators. To further interpret the functional relevance of high-scoring SVs, we integrated epigenetic data and developed a modified Activity-by-Contact scoring approach to prioritize SVs with disrupted genome contacts at active enhancers. This method highlighted highly disruptive SVs near key oncogenes, as well as novel candidate loci potentially implicated in tumorigenesis. These findings highlight the utility of machine learning for identifying novel SVs, loci, and genetic mechanisms contributing to pediatric cancers. This framework provides a foundation for future studies linking SV-driven regulatory changes to cancer pathogenesis.

Indexed as

ChromatinGenomic Structural VariationMachine LearningNeoplasmsChildConvolutional Neural NetworksHumansChromatin

Identifiers

PMID41904260
PMCPMC13039956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.